This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Nan Jia
Introduction
Nan Jia is an accomplished inventor based in West Lebanon, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on advancing diagnostic and therapeutic methods that can improve patient outcomes.
Latest Patents
Nan Jia holds a patent for "Anti-glucagon antibodies and uses thereof." This patent includes monoclonal antibodies or antigen-binding fragments that specifically bind to glucagon. These antibodies are instrumental in immunoassays for measuring glucagon levels and can be utilized in various imaging methods for diagnostic, prognostic, and predictive purposes. The innovation aims to optimize therapeutic regimens for patients where glucagon signaling plays a critical role in disease progression.
Career Highlights
Nan Jia is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development in the field of immunology, where he applies his expertise to create innovative solutions for complex health issues. His dedication to advancing medical science is evident in his patent and ongoing research efforts.
Collaborations
Nan Jia collaborates with notable colleagues, including David Edward Watson and John Harrison Sloan. Their combined expertise fosters a productive environment for innovation and discovery in the field of biotechnology.
Conclusion
Nan Jia's contributions to the field of immunology through his patent on anti-glucagon antibodies exemplify the impact of innovative research in healthcare. His work at Eli Lilly and Company continues to pave the way for advancements in diagnostic and therapeutic strategies.